BioCentury
ARTICLE | Politics & Policy

Democratic drug pricing bill would kill 100 drugs in 10 years, White House economic advisers say

December 3, 2019 10:11 PM UTC
Updated on Dec 4, 2019 at 1:24 AM UTC

The White House Tuesday attacked the Lower Drug Costs Now Act of 2019 (H.R. 3), a bill supported by House Speaker Nancy Pelosi (D-Calif.), and reiterated its support for the Prescription Drug Pricing Reduction Act of 2010 (S. 2543), co-sponsored by Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.).

In a brief statement, the White House Council of Economic Advisers (CEA) predicted that H.R. 3 would have catastrophic effects on drug development. CEA stated that the bill “could lead to as many as 100 fewer drugs entering the United States market over the next decade, or about one-third of the total number of drugs expected to enter the market during that time.”...